Clinical Results


“Better durability for the BCA graft than for ePTFE grafts in patients whose anatomy preclude placement of an arteriovenous fistula.”*

* Bovine carotid artery biologic graft outperforms expanded polytetrafluoroethylene for hemodialysis access
Journal of Vascular Surgery, Volume 65, Issue 3, March 2017

Clinically Documented

“120 grafts studied: 52 (43%) were BCA and 68 (57%) were ePTFE. Successful graft use for dialysis was 96% for BCA and 84% for ePTFE.”

“There were no differences in primary and primary assisted patency for BCA compared with ePTFE. However, secondary patency was higher for BCA compared with ePTFE.”

“Graft infection rates during the study period were 15.4% for BCA and 20.6% for ePTFE.”


“Bovine carotid artery graft appears to be a viable alternative, especially in patients requiring urgent revascularization, that does not significantly compromise patency, limb salvage, or functional outcomes.” *

* Comparison of Autologous Vein and Bovine Carotid Artery Graft as a Bypass Conduit in Arterial Trauma
Annals of Vascular Surgery, Volume 61, November 2019

Clinically Documented

“Thirty patients were included in this study. Seventeen (57%) injuries were to the lower extremity (LE) and 13 (43%) to the upper extremity. Bovine carotid artery graft was used as a conduit in 12 (40%) cases, while autologous vein was used in 18 (60%) patients.”

“Overall limb salvage was 90%: bovine versus autologous vein (82% vs. 94%; P = 0.28). There were no early or late graft infections with either conduit. There were no significant differences in ambulatory status at discharge by graft type. Overall survival was 100%.”